Skip to main content

Table 4 Predictors of progression to CDR 1 at 1-year follow-up using logistic regression analysis

From: Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment

 

Univariate

OR (95% CI), p value

Multivariate

OR (95% CI), p value

Age

1.018 (0.933–1.115), 0.685

1.030 (0.934–1.146), 0.549

Female

2.739 (0.577–19.913), 0.242

2.089 (0.314–1.805), 0.455

Education

0.929 (0.784–1.108), 0.395

1.081 (0.885–1.357), 0.453

Amyloid PET positivity

1.727 (0.397–9.072), 0.479

3.925 (0.676–34.315), 0.157

Baseline MMSE

0.662 (0.451–0.895), 0.015

0.606 (0.381–0.873), 0.015

ChEI use

1.312 (0.305–5.975), 0.713

1.120 (0.204–6.238), 0.892